Academic Journal
ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: IS THERE A REASON TO CONSIDER AN EQUIVALENCE OF TWO DRUG CLASSES FROM THE EVIDENCE BASED MEDICINE STANDPOINT
| Τίτλος: | ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: IS THERE A REASON TO CONSIDER AN EQUIVALENCE OF TWO DRUG CLASSES FROM THE EVIDENCE BASED MEDICINE STANDPOINT |
|---|---|
| Συγγραφείς: | S. Yu. Martsevich |
| Πηγή: | Рациональная фармакотерапия в кардиологии, Vol 9, Iss 4, Pp 427-432 (2015) |
| Στοιχεία εκδότη: | Столичная издательская компания, 2015. |
| Έτος έκδοσης: | 2015 |
| Συλλογή: | LCC:Therapeutics. Pharmacology LCC:Diseases of the circulatory (Cardiovascular) system |
| Θεματικοί όροι: | ингибиторы ангиотензинпревращающего фермента, антагонисты рецепторов ангиотензина, отдаленные результаты лечения, Therapeutics. Pharmacology, RM1-950, Diseases of the circulatory (Cardiovascular) system, RC666-701 |
| Περιγραφή: | The results of the main large controlled trials that had proven effect of ACE inhibitors (ACEi) and angiotensin receptor blockers (ARB) on cardiovascular diseases outcomes are evaluated. Data of the recent meta-analyzes comparing ACEi and ARB effects on the life prognosis in patients of the high cardiovascular risk are presented. Better validity of ACEi efficacy versus this of ARB is concluded. |
| Τύπος εγγράφου: | article |
| Περιγραφή αρχείου: | electronic resource |
| Γλώσσα: | English Russian |
| ISSN: | 1819-6446 2225-3653 |
| Relation: | http://www.rpcardio.ru/jour/article/view/108; https://doaj.org/toc/1819-6446; https://doaj.org/toc/2225-3653 |
| DOI: | 10.1234/1819-6446-2013-4-427-432 |
| Σύνδεσμος πρόσβασης: | https://doaj.org/article/8b388ee11a6f4bd3af3d28080aa7c3ef |
| Αριθμός Καταχώρησης: | edsdoj.8b388ee11a6f4bd3af3d28080aa7c3ef |
| Βάση Δεδομένων: | Directory of Open Access Journals |
| ISSN: | 18196446 22253653 |
|---|---|
| DOI: | 10.1234/1819-6446-2013-4-427-432 |